National Coverage Analysis (NCA)

Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer

CAG-00422N

Expand All | Collapse All

Contacts

David Dolan
David.Dolan@cms.hhs.gov
410-786-3365
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID
Original Consideration Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer CAG-00422N You are here